Posted by: Jon Moulton
Posted on: Tue, Jan 29, 2013, 12:44 pm CST

Pérez B, Gutiérrez-Solana LG, Verdú A, Merinero B, Yuste-Checa P, Ruiz-Sala P, Calvo R, Jalan A, Marín LL, Campos O, Ruiz MA, Miguel MS, Vázquez M, Castro M, Ferrer I, Navarrete R, Desviat LR, Lapunzina P, Ugarte M, Pérez-Cerdá C.  Clinical, biochemical, and molecular studies in pyridoxine-dependent epilepsy. Antisense therapy as possible new therapeutic option.  Epilepsia. 2013 Jan 25. doi: 10.1111/epi.12083. [Epub ahead of print]